Danone Q2 Sales Up 4.2% on Demand for High-Protein Dairy and Specialised Nutrition
Danone's robust Q2 2026 performance, with like-for-like sales growth of 4.2%, highlights sustained consumer demand for high-protein dairy and specialised nutrition products amidst inflationary pressures. Strategic acquisitions and portfolio refinement underscore a clear focus on health-aligned categories.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 29 July 2026
Danone reported a strong Q2 2026 performance with total sales reaching €7.22 billion, a 4.2% like-for-like increase. This growth was underpinned by resilient consumer demand for high-protein dairy, specialised nutrition, and bottled water categories. Volume and mix contributed 1.9% to this growth, with pricing accounting for the remaining 2.3%, signalling effective navigation of persistent inflationary challenges.
Specialised Nutrition sales saw a 4.5% like-for-like rise, reflecting robust performance across geographical regions. The Essential Dairy & Plant-Based category delivered a 3.8% like-for-like growth, driven by continued interest in functional dairy products, particularly high-protein offerings such as Skyr and Kefir, alongside expanded plant-based ranges. Danone's expansion of its Silk Protein line into plant-based yoghurts and shakes illustrates a strategic alignment with market trends integrating protein, fibre, and prebiotics for gut health and overall well-being. Regionally, Asia Pacific led with 5.2% growth, followed by the Americas at 4.3% and EMEA at 3.6%.
CEO Antoine de Saint-Affrique highlighted the relevance of Danone's health-focused portfolio. The company maintains its 2026 guidance of 3-5% like-for-like sales growth, with recurring operating income expected to outpace sales growth, affirming confidence in its value creation model.
What this means for United Kingdom
UK brand owners must immediately analyse their high-protein and specialised nutrition portfolios for competitive positioning, given Danone's sustained Q2 growth in these sectors. Reformulation windows should focus on incorporating fibre and prebiotics alongside protein to meet the evolving functional health demands observed in Danone's Silk Protein expansion. Procurement leads should anticipate potential raw material cost pressures for high-quality protein sources due to increased demand from major players. Furthermore, the robust performance of specialist nutrition implies heightened marketing investment in clinically substantiated products, which will intensify competition for shelf space and consumer attention in Boots and Holland & Barrett, necessitating distinct value propositions.
Many leading brands in this category are manufactured in partnership with Supplement Factory.